Explore our resources by research/diagnostic specialty or content type

ALPCO announced the launch of its new STELLUX^® Chemiluminescent Human C-peptide ELISA on December 5, 2014. This highly characterized assay measures C-peptide requiring only 50 µL of human serum, plasma or cell culture supernatant.

The ELISA exhibits greater sensitivity and a broader dynamic range compared to other commercially available C-peptide ELISAs on the market. Like the previous STELLUX^® Chemiluminescent assays available from ALPCO, the STELLUX^® Human C-peptide ELISA includes 3 control levels, as well as a lot specific validation package, providing confidence in quality and performance. The assay is run on a standard glow chemiluminescent plate reader common in most research laboratories.